bronchiolitis
BRONCHIOLITIS
Bronchiolitis is a clinical diagnosis preceding upper respiratory illness and/or rhinorrhea.
Signs of respiratory illness which may include wheezing, retractions, oxygen desaturation, color change, nasal flaring.
There is also presence of apnea especially in premature or low birthweight infants, signs of dehydration and exposure to persons with viral upper respiratory infections.
Symptoms are usually worst on the 3rd-5th day of illness and then improve gradually.

Bronchiolitis Signs and Symptoms

Introduction

  • Bronchiolitis is a disease of the lower respiratory tract characterized by acute inflammation & edema of the bronchioles, accompanied by increased mucus production
  • Usually affects children <2 years of age
  • Among the leading causes of hospitalization of infants in the United States and Asia

Etiology

  • Majority of cases are caused by the respiratory syncytial virus (RSV)
  • Other etiologic agents include rhinovirus, adenovirus, parainfluenza, Mycoplasma
  • There is no evidence of bacterial etiology for bronchiolitis, but bacterial superinfection may occur
    • Otitis media is the most common bacterial infection associated w/ bronchiolitis
Pathogenesis
  • Epithelial necrosis, mucus hypersecretion, round-cell infiltration, and submucosal inflammation brought about by RSV infection causes bronchiolar narrowing, which leads to mucus plug formation, bronchiolar obstruction, and distal lung tissue overinflation, resistance, and collapse

Signs and Symptoms

  • Symptoms are usually worst on the 3rd-5th day of illness, & then improve gradually
  • Preceded by upper respiratory infections
  • Initially sneezing, mild rhinorrhea, nasal obstruction, cough
  • May progress to respiratory distress w/ wheezing, crackles, irritability, shortness of breath, tachypnea
    • Lower respiratory tract infection (mainly bronchiolitis & pneumonia) should be suspected w/ increased respiratory rate (RR)
  • Anorexia, fever (<39°C)
    • Other diagnosis should be considered 1st in the presence of axillary temperature of ≥39°C
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 3 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 2 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.